Benzodiazepine effects on human sleep EEG spectra: A comparison of triazolam and flunitrazepam

Life Sciences

Volumn 63, Issue 8, 1998, Pages 675-684

  Tan, Xin ^b   Uchida, Sunao ^a   Matsuura, Masato ^b   Nishihara, Kyoko ^b   Iguchi, Yoshinobu ^b   Kojima, Takuya ^b  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b NONE

Author keywords

Flunitrazepam; Sleep EEG; Spectral analysis; Triazolam

Indexed keywords

BENZODIAZEPINE DERIVATIVE; FLUNITRAZEPAM; TRIAZOLAM;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG HALF LIFE; ELECTROENCEPHALOGRAM; FOURIER TRANSFORMATION; HUMAN; HUMAN EXPERIMENT; MALE; NEUROMODULATION; NONREM SLEEP; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; REM SLEEP; SLEEP TIME; SLEEP WAKING CYCLE;

ADULT; ELECTROENCEPHALOGRAPHY; FLUNITRAZEPAM; HUMANS; MALE; SLEEP; TRIAZOLAM;

EID: 18844474865     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00318-X     Document Type: Article

References (27)

1. 1. D.J. GREENBLATT, J. Clin. Psychiat. 52 (9, suppl) 4-10 (1991).
2. 2. D.J. GREENBLATT, J. Clin. Psychiat. 53 (6, suppl) 7-13 (1992).
3. 3. C. OGURA, K. NAKAZAWA, K. MAJIMA, K. NAKAMURA, H. UEDA, Y. UMEZAWA and W.M. WARDELL, Psychopharmacology. 68 61-65 (1980).
4. 4. A.N. NICHOLSON and B.M. STONE, Br. J. Clin. Pharmac. 9 187-194 (1980).
5. 5. D.D. BREIMER, Br. J. Clin. Pharmac. 8 7S-13S (1979).
6. 6. H. FRIEDMAN, D.J. GREENBLATT, E.S. BURSTEIN, J.S. HARMATZ and R.I. SHADER, Br. J. Clin. Pharmac. 22 639-642 (1986).
7. 7. D.W. HOMMER, V. MATSUO, O. WOLKOWITZ, G. CHROUSOS, D.J. GREENBLATT, H. WEINGARTNER and S. PAUL, Arch. Gen. Psychiatry. 43 542-551 (1986).
8. 8. A. KALES, M.B. SCHARF and J.D. KALES, Science. 201 1039-1041 (1978).
9. 9. H. FUKAZAWA, H. ICHISHITA, M. HONDA and H SHIMIZU, Clin. Pharmac. 9 (3) 251-265 (1978).
10. 10. S. UCHIDA, N. OKUDAIRA, K. NISHIHARA and Y. IGUCHI, Life Sci. 58 199-205 (1996).
11. 11. S. UCHIDA, N. OKUDAIRA, K. NISHIHARA, Y. IGUCHI and X. TAN, Life Sci. 59 117-120 (1996).
12. 12. A. RECHTSCHAFFEN and A. KALES, Public Health Service, U.S. Government printing office (1968).
13. 13. I. FEINBERG, J. Psychiat. Res. 10 283-306 (1974).
14. 14. J.M. GAILLARD, P. SCHULZ and R. TISSOT, Pharmakopsychiat. 6 207-217 (1973).
15. 15. G. VOGEL, A. THURMOND and P. GIBBONS, Psychopharmacologia (Berl.). 41 65-69 (1975).
16. 16. A.A. BORBELY, P. MATTMANN, M. LOEPFE, I. STRAUCH and D. LEHMANN, Human Neurobiol. 4 189-194 (1985).
17. 17. T.M. ITIL, B. SALETU and J. MARASA, Pharmakopsych. 240 265-280 (1974).
18. 18. M. STERIADE, D.A. MCCORMICK and T.J. SEJNOWSKI, Science. 262 679-685 (1993).
19. 19. S. UCHIDA, T. MALONEY and I. FEINBERG, Brain Res. 659 243-248 (1994).
20. 20. T. KOBAYASHI, Y. KIUCHI, H. SHIMZU, J. TAKEUCHI, H. OGATA and M. TORU, Ann. Rep. Pharmacopsychiat. Res. Found. 20 113-120 (1989).
21. 21. W. VELDKAMP, R.N. STRAW, C.M. METZLER and H.V. DEMISSIANOS, J. Clin. Pharmacol. 14 102-111 (1974).
22. 22. V.A. FESHCHENKO, R.A. VESELIS and R.A. REINSEL, Neuropsychobiology. 35 211-220 (1997).
23. 23. H. FRIEDMAN, D. J. GREENBLATT and G. R. PETERS, Clin. Pharmacol. Ther. 52 (2) 139-150 (1992).
24. 24. C. TOMAZ, H. DICKINSON-ANSON and J.L. MCGAUGH, Brain Res. 568 85-91 (1991).
25. 25. C. TOMAZ, H. DICKINSON-ANSON, J.L. MCGAUGH, M.A. SOUZA-SILVA, M.B. VIANA and F.G. GRAEFF, Behav. Brain Res. 58 99-105 (1993).
26. 26. M.A.D.S. SILVA and C. TOMAZ, Neuropsychobiology. 32 31-36 (1995).
27. 27. T. ROTH and T.A. ROEHRS, J. Clin. Psychiatry. 53 (6, suppl) 14-18 (1992).